公开(公告)号：EP1240158A1

公开(公告)日：2002-09-18

申请号：EP00984165.1

申请日：2000-12-11

申请人： Amgen Inc.,

发明人： DOMINGUEZ, Celia ,  CHEN, Guoqing ,  XI, Ning ,  XU, Shimin ,  HAN, Nianhe ,  LIU, Qingyian ,  HUANG, Qi ,  SIEGMUND, Aaron ,  HANDLEY, Michael ,  LIU, Longbin ,  KISELYOV, Alexander S.

IPC分类号： C07D401/12 ,  C07D417/14 ,  C07D401/14 ,  C07D407/14 ,  C07D409/12 ,  C07D207/277 ,  A61K31/4025 ,  A61P19/00 ,  A61P35/00

CPC分类号： C07D207/277 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D417/14

摘要： The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as αvβ3, αvβ5, αvβ6, α5β1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.